Anna Maria Wiesinger

Anna Maria Wiesinger is a researcher at the Institute for Inborn Metabolic Diseases at Paracelsus Medical University. Her work focuses on pharmacology and personalized medicine for rare diseases, particularly lysosomal storage disorders like mucopolysaccharidosis.

• Mag. pharm. (Master of Pharmacy)
• Dr. phil. (Doctor of Philosophy)

Her research develops clinical tools for precision medicine, including suspicion index development and individualized treatment trials for immunomodulatory drugs. Recent publications emphasize improving diagnosis accuracy and treatment accessibility for rare metabolic diseases.

Key awards include:

• Sanofi Medical Award (2023)
• WORLD Symposium Young Investigator Award (2023)

She collaborates with organizations like the European Society for Pediatric Pharmacology and contributes to journals such as ORPHANET JOURNAL OF RARE DISEASES and JOURNAL OF INHERITED METABOLIC DISEASE.